Stefan Ioannou: Copper, Nickel and Zinc Won't Be Cheap for Long
Source: Kevin Michael Grace of The Mining Report  (10/21/14)
The all-powerful U.S. dollar is currently hammering base metals and base metal equities. Haywood Securities Mining Analyst Stefan Ioannou says that increasing demand and near-term supply shortages make base metals a bargain that won't last. In this interview with The Mining Report, Ioannou argues that juniors with good deposits and low costs are in a unique position to benefit, and lists several companies that look to do just that. More >

Chinese and Indian Gold Buyers Back in Market in a Big Way
Source: Lawrence Williams, Mineweb  (10/21/14)
"By all accounts, demand in the two biggest consuming nations has been soaring, and they are, between them, taking in virtually everything the world's gold mines can produce." More >

An Ebola Armageddon Could Trigger a Rebirth in Gold and Silver Prices: Eric Sprott
Source: JT Long of The Gold Report  (10/20/14)
Could an infectious disease kill the monster that has been choking gold and silver prices for more than a year? On the heels of a lively Sprott Precious Metals Roundtable discussion, The Gold Report caught up with investor Eric Sprott to ask how a tragedy in Africa could impact the price of precious metals and mining stocks. We also spoke to his Executive Vice President of Corporate Development John Ciampaglia about a new way to gain exposure to gold. More >

A Year of Hard-Wrought Lessons for Platinum
Source: Duduzile Ramela, Moneyweb  (10/20/14)
"Mechanization is becoming more viable; we're going to see a more skilled workforce..." More >

The Evolution of the Cancer Cure
Source: Ray Blanco, The Daily Reckoning  (10/20/14)
"Provided new therapies keep becoming available, a cancer patient can sometimes "hitchhike" from one to the next for a long time." More >

Leading Indicators for Gold's Turnaround
Source: Jordan Roy-Byrne, The Daily Gold  (10/17/14)
"While gold has only recently emerged from a weak triple bottom, it is showing more strength against the other asset classes." More >

Three Ways to Play Uranium: Dundee's David Talbot Names His Top Draft Picks
Source: Tom Armistead of The Energy Report  (10/16/14)
Investors in the uranium space are like Goldilocks: They have three major ways to play, says David A. Talbot, senior mining analyst at Dundee Capital Markets. The Athabasca Basin entices with high rewards for high risks. U.S.-based in-situ recovery offers stable cash flow from stable operations. And companies challenged by current market prices that are positioning themselves smartly for an upswing also provide opportunity. In this interview with The Energy Report, Talbot explains the turbulent currents roiling the uranium space, and names eight players he thinks are positioned just right. More >

How to Bargain Hunt for Hot Biotechs: Edison's Pooya Hemami
Source: Peter Byrne of The Life Sciences Report  (10/15/14)
Every business day, Edison Investment Research Analyst Pooya Hemami scours the global markets for life science companies with upside flowing through their product pipelines. In this interview with The Life Sciences Report, Dr. Hemami tells us where to look for biotech bargains, including a few top-fliers and a handful of companies that have experienced temporary setbacks but are poised for blue sky. More >

H.C. Wainwright Analyst Jeff Wright Names Three Companies that Could Turn the Gold Trend Upside Down
Source: JT Long of The Gold Report  (10/15/14)
Fans of gold have been following Federal Reserve Board announcements for any sign of relief, but H.C. Wainwright & Co. Analyst Jeff Wright says change may be a long time coming. That is why in this interview with The Gold Report, Wright is focusing on three companies that can be successful even in a low gold price environment. He also offers three questions every investor should ask before buying a junior mining stock.
More >

Shabbvie Marks Difference Between Great and Exceptional Deal Quarter
Source: EP Vantage  (10/15/14)
"The summer slowdown was officially cancelled this year as $100B of third-quarter mergers and takeovers blasted the previous period into oblivion—or at least this is how things stood before news emerged that AbbVie was having second thoughts about buying Shire." More >

John Kaiser's Tips for Escaping the Resource Sector Swamp Alive
Source: JT Long of The Mining Report  (10/14/14)
What if the goldbugs are wrong and fiat currency isn't going to throw the world into hyperinflation? What if, instead, a steadily growing economy and a new awareness of the importance of having security of supply for critical metals, along with a big exciting discovery that heats up the resource sector, are what pull sinking gold and silver prices and their related mining companies out of the muck? If so, John Kaiser tells The Mining Report that he has set his sights on the dozen companies that would star in this horror-turned-romantic epic adventure. More >

A Win-Win Scenario for Gold Investors
Source: James Rickards, The Daily Reckoning  (10/14/14)
"Investors can use recent setbacks to acquire gold at more attractive prices while waiting for the inevitable price increase to occur." More >

Don't Miss Your Chance to Profit from the End of OPEC
Source: Matt Insley, The Daily Reckoning  (10/14/14)
"A decade ago would you ever imagine that a U.S.-led oil boom would cause a panic among OPEC nations?" More >

Must Read: 10 Companies Adrian Day Sees as Stable in a World that Is Not
Source: Peter Byrne of The Gold Report  (10/13/14)
Fund Manager Adrian Day has a ready answer for investors wondering why the gold price has been so depressed. It is the strength of the dollar. The Bank of Japan can act like a drunken sailor buying bonds at negative interest rates and the European Central Bank can do all the quantitative easing it wants, but as long as the dollar remains high, the gold price will suffer. That is why, in this interview with The Gold Report, Day focuses on 10 companies that can remain stable at almost any price. More >

Will Russia and South Africa Become the OPEC of Platinum?
Source: Teresa Matich, Resource Investing News   (10/12/14)
"Bloomberg reported last Wednesday that Russia and South Africa will meet next month to discuss their mutual interest in the white metals, and the possibility of bolstering prices." More >

Griffin Securities' Keith Markey on the Promise of RNAi and Synthetic Biology
Source: Michael Goodman of The Life Sciences Report  (10/9/14)
Griffin Securities has assembled a biotech portfolio weighted toward companies pursuing high-science therapeutic approaches. However, as analyst Keith Markey explains, through a combination of pipeline diversification, positive clinical data, and low-cost research and development strategies, many companies are able to mitigate the risk inherent in their technologies. In this interview with The Life Sciences Report, Markey discusses near-term catalysts for some of the names he follows. More >

Energy Master Limited Partnerships Go Mainstream: Baird's Ethan Bellamy
Source: Peter Byrne of The Energy Report  (10/9/14)
As Robert W. Baird & Co.'s Ethan Bellamy explains, master limited partnerships are yield-producing investments that can bring remarkable returns to smart investors and provide short-term buy-sell profits. In this interview with The Energy Report, Bellamy discusses a fistful of partnerships worth an investor's dollars. More >

David Morgan's Secret to Being Grateful, Even at $17 Silver
Source: JT Long of The Gold Report  (10/8/14)
Manipulation and apathy can't keep silver prices down forever; there is too much demand and too much money sitting on the sidelines. In this interview with The Gold Report,
Silver-Investor.com Editor David Morgan tells us why he is grateful for his balanced approach to investing and life. He also explains why he is still excited about four developers that are moving projects forward at any price.
More >

The History of Metals
Source: Visual Capitalist  (10/8/14)
"The development of civilization has relied heavily on the discovery of metals." More >

Traders' Infatuation with Ebola Drugs Causing 'Rollercoaster' Market, Says Tekmira CEO
Source: Riley McDermid, BioSpace  (10/8/14)
"Stocks of MAP Pharmaceuticals, which produced the first successful Ebola treatment, ZMapp, and those of Chimerix, which has had its antiviral, brincidofovir, approved for experimental treatment, have all climbed by double digits as the virus has spread globally." More >

The U.S. Oil Export Surge Is Coming
Source: Kent Moors, Money Morning  (10/8/14)
"Something is now afoot in the Pacific Northwest that is going to change how we think about pricing oil—and this new wrinkle is going to provide a range of fantastic opportunities for investors." More >

The Best Offense Remains a Good Defense: M Partners' Derek Macpherson
Source: JT Long of The Mining Report  (10/7/14)
With a strong dollar currently depressing the precious metals prices, M Partners Mining Analyst Derek Macpherson believes that fundamentals will kick in eventually and bring prices back up. In this interview with The Mining Report, he advises investors to look for low-risk companies on solid footing and discusses some of his favorite names that are poised to come out fighting. More >

Catalyst Check: Natural Resources Watchlist at Three Months
Source: JT Long of The Gold Report  (10/6/14)
At the Cambridge House Canadian Investment Conference in June, The Gold Report Publisher Jason Mallin asked a panel of experts picking a portfolio of stocks with upside potential for the 2014 Streetwise Reports Natural Resources Watchlist what they wanted to see in an equity. As always, Sprott US Holdings Inc. CEO Rick Rule, summed up the ideal beautifully. "We like reality at a discount," he said. Now that three months have passed, we decided to check in with Rick and co-panelists Joe Mazumdar from Canaccord Genuity and Keith Schaefer from Oil & Gas Investments Bulletin to see how that reality is playing out. You can always check the portfolio in real time at the Portfolio Tracker. More >

Deutsche Bank Favors Base Metals over Precious Metals
Source: Dorothy Kosich, Mineweb  (10/6/14)
"Base metals are preferred over bulks and precious metals, said Deutsche Bank analysts in a recently published third-quarter preview." More >

A Tour of Australian Biotechs with Morgans’ Scott Power
Source: Peter Byrne of The Life Sciences Report  (10/2/14)
Australia is a powerhouse for medical science innovations, and nobody understands that better than Scott Power of Morgans Financial Ltd. Power watched the weaker Australian firms go the way of the dodo bird during the downturn in the biotech sector earlier this year, leaving only the fittest for investors to choose from. In this interview with The Life Sciences Report, he identifies a promising selection of survivors—biotechs with the power to rejuvenate an evolving portfolio. More >